NPI: 1194185223 · HAMPTON, VA 23669 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/02/2016
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 03/02/2016 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,025 | $107K |
| 2019 | 12,112 | $155K |
| 2020 | 10,099 | $177K |
| 2021 | 11,368 | $267K |
| 2022 | 6,833 | $280K |
| 2023 | 3,213 | $197K |
| 2024 | 1,914 | $146K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 20,431 | 1,685 | $1.31M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 17,612 | 934 | $12K |
| A4657 | Syringe, with or without needle, each | 3,771 | 1,159 | $6K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 38 | 24 | $2K |
| J1756 | Injection, iron sucrose, 1 mg | 3,438 | 739 | $1K |
| J1270 | Injection, doxercalciferol, 1 mcg | 10,078 | 824 | $343.21 |
| 83970 | 429 | 332 | $50.78 | |
| 82728 | 285 | 212 | $15.33 | |
| 83550 | 291 | 213 | $9.84 | |
| 83540 | 285 | 212 | $7.30 | |
| 85041 | 442 | 373 | $1.43 | |
| 85048 | 431 | 367 | $1.22 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 33 | 15 | $0.00 |